PATENT CLAIM ANALYSIS

Application Number: 16014295
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "210210"]

Abstract:
Provided are benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof. Also provided is a method for treating cancer by using a pharmaceutical composition including the benzenesulfonamide derivatives or pharmaceutically acceptable salts thereof and pharmaceutically acceptable carriers.

Claim (Index 14):
The method of  claim 13 , wherein the cancer is liver cancer or lung cancer.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15387221', '15036384', '14361548', '14453502', '15566872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7176595695716337
- 35 USC 102 Novelty (BERT): 0.4870420490407015
- Combined Prediction Score: 0.6945978175185404
- Mean Citation Score: 169.93924199999995
- Max Citation Score: 180.09967
- Similarity Product: 133.83636717250943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test